Yield10 Bioscience Announces Second Quarter 2024 Financial Results
14 août 2024 16h37 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the...
Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil
08 janv. 2024 08h31 HE
|
Yield10 Bioscience, Inc.
Yield10 Bioscience files RSR with USDA-APHIS for elite Camelina designed to produce EPA/DHA omega-3 oils
Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research
18 oct. 2023 08h31 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has...
Yield10 Bioscience Files Request for Regulatory Status Review under USDA-APHIS’s SECURE Rule Covering Elite Camelina Designed to Produce the EPA Component of Omega-3 Oil
26 juil. 2023 08h40 HE
|
Yield10 Bioscience, Inc.
-Omega-3 (EPA) Camelina planted at acre-scale in US nearing maturity -Development program moving forward at a solid pace toward commercialization WOBURN, Mass., July 26, 2023 (GLOBE NEWSWIRE) --...
Yield10 Bioscience Names Willie Loh, Ph.D., Former Cargill Executive, as Special Commercial and Technical Advisor
27 avr. 2022 09h15 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today named Willie Loh, Ph.D., as a special...
Yield10 Bioscience Announces Fourth Quarter and Full Year 2021 Financial Results
09 mars 2022 16h02 HE
|
Yield10 Bioscience, Inc.
-Near-term commercial focus on the Renewable Diesel market -Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update WOBURN,...
Yield10 Bioscience Announces Closing of $12.7 Million Public Offering
03 févr. 2021 12h15 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten...